相关实验视频
Updated: May 2, 2026

08:45
Polygraphic Recording Procedure for Measuring Sleep in Mice
Published on: January 25, 2016
23.4K
适度早产婴儿的扩大咖啡因:MoCHA随机临床试验
Waldemar A Carlo1, Eric C Eichenwald2, Benjamin A Carper3
1Department of Pediatrics, Division of Neonatology, University of Alabama at Birmingham.
JAMA
|April 28, 2025
概括
延长对中度早产婴儿的咖啡因治疗并没有缩短住院时间. 这项研究发现咖啡因和安慰剂组之间的住院时间或生理成熟度没有显著差异.
科学领域:
- 新生儿学
- 儿童药物学
- 临床试验
背景情况:
- 在停用咖啡因后,由于早产性呼吸暂停,可能会延长中度早产婴儿的住院时间.
- 优化治疗时间对于降低医疗费用和改善婴儿健康状况至关重要.
研究的目的:
- 调查延长咖啡因酸盐治疗是否会减少中度早产婴儿住院时间.
- 评估延长咖啡因对生理成熟度和其他临床结果的影响.
主要方法:
- 一项随机临床试验,涉及29个美国医院的827名怀孕29至33周的婴儿.
- 婴儿在出院后28天接受口服咖啡因酸盐或安慰剂,并于2023年3月完成随访.
- 主要结局是离院几天;次要结局包括生理成熟度,再入院和不良事件.
主要成果:
- 与安慰剂相比,继续服用咖啡因并没有显著缩短住院时间 (18. 0 vs 16. 5 天).
- 在生理成熟的几天,完全口服养,再入院或病诊期间没有发现显著差异.
- 接受咖啡因治疗的婴儿更快地达到无呼吸状态,但这并没有导致整体住院时间缩短.
结论:
- 延长咖啡因治疗超出标准方案似乎不会减少中度早产婴儿的住院时间.
- 这些发现表明目前的咖啡因戒断策略适合这一群体.
- 进一步的研究可能会探索用于管理早产性呼吸暂停和优化出院时间的替代干预措施.
相关概念视频
Experimental Designs
11.3K
An experimental design is a systematic process that allows researchers to evaluate the relationship between dependent and independent variables. There are three widely used types of experimental design - pre-experimental design, true experimental design, and quasi-experimental design. In pre-experimental design, the researcher compares the data before and after some interventions or treatments. The true-experimental design has more than one purposefully created group, a commonly measured...
11.3K
Teratogenicity
4.2K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Bioavailability Study Design: Single Versus Multiple Dose Studies
383
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
383
Bioavailability Study Design: Healthy Subjects Versus Patients
248
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
248

